Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Johnson & Johnson - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
JNJ
New York
2834
https://www.jnj.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Johnson & Johnson
4 Dividend Kings Poised for Growth, According to Analysts
- May 3rd, 2024 9:04 pm
30 Most Profitable Companies with Highest Margins in the World
- May 3rd, 2024 6:41 pm
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
- May 3rd, 2024 1:10 pm
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
- May 3rd, 2024 1:00 pm
Intuitive Surgical Builds On Its Robotic Surgery Prowess. But Challengers Are Coming.
- May 3rd, 2024 12:30 pm
3 Dividend Growth Stocks that Just Raised Their Payouts
- May 3rd, 2024 12:30 pm
Shareholders in Johnson & Johnson (NYSE:JNJ) are in the red if they invested three years ago
- May 3rd, 2024 12:00 pm
25 Most Profitable Companies in the US
- May 2nd, 2024 4:20 pm
Janssen-Cilag seeks expanded EMA approval for TREMFYA
- May 2nd, 2024 10:51 am
The top pharmaceutical companies by R&D expenditure
- May 2nd, 2024 7:01 am
Decoding Johnson & Johnson (JNJ): A Strategic SWOT Insight
- May 2nd, 2024 5:04 am
US STOCKS-S&P 500, Nasdaq end lower after Fed rate decision, Powell press conference
- May 1st, 2024 8:26 pm
Sector Update: Health Care Stocks Rise Late Afternoon
- May 1st, 2024 8:11 pm
US not suffering from ‘stagflation’, says Fed chairman Jerome Powell
- May 1st, 2024 8:07 pm
US STOCKS-S&P 500 ends lower after Fed rate decision, Powell press conference
- May 1st, 2024 8:00 pm
Johnson & Johnson’s latest gambit to solve its massive talcum powder asbestos issue: A $6.5 billion settlement, paid out over 25 years
- May 1st, 2024 7:48 pm
J&J Offers $6.5 Billion for Talc Lawsuits Ahead of Third Bankruptcy Filing
- May 1st, 2024 4:27 pm
Janssen adopts J&J name as part of global rebranding effort
- May 1st, 2024 3:02 pm
J&J Seeks Backing for $11 Billion Baby Powder Cancer Deal
- May 1st, 2024 2:23 pm
Update: Johnson & Johnson Announces $6.48 Billion Plan for Unit to Resolve Ovarian Cancer Talc Claims
- May 1st, 2024 2:15 pm
Scroll